ADS Basic Science Symposium: Preclinical Insights into Metabolic Disease: Pathways to Remission and Progression
Tracks
Breakout 2: Room 6
Thursday, August 21, 2025 |
2:30 PM - 3:30 PM |
Room 6 |
Speaker
Dr Stewart Masson
Postdoctoral Researcher
The University of Sydney
Pseudotemporal dissection of obesity in Diversity Outbred mice
2:30 PM - 3:00 PMBiography
Dr Masson completed his PhD in 2021 at the University of Auckland, New Zealand on insulin signalling and the role of beta-catenin in skeletal muscle glucose transport with Professor Peter Shepherd and Associate Professor Troy Merry. He then moved to the University of Sydney to continue his work on insulin action and metabolism with Professor David James. His work now focusses on the genetics of metabolic disease and insulin resistance.
Dr Adam Rose
Associate Professor (Research)
Monash University
Preclinical type 2 diabetes remission through amino acid restriction
2:30 PM - 3:00 PMBiography
Dr Adam Rose studied Exercise Science at Griffith University. He went on to complete an Honours degree and PhD at Deakin University with Prof. Mark Hargreaves studying exercise metabolism, biochemistry and skeletal muscle signalling. He conducted his junior post-doctoral training with Prof. Erik Richter at Copenhagen University continuing on studies of skeletal muscle signalling, adaptation and metabolism. He then joined Prof. Stephan Herzig at the German Cancer Research Center as a Senior Scientist and subsequent Sub-Group Leader studying liver metabolic-hormonal signalling and systemic metabolic control in health and disease. He joined Monash University in August 2017 as a Senior Research Fellow and Head of the Nutrient Metabolism and Signalling Laboratory within the Dept. of Biochemistry and Molecular Biology as part of the Biomedicine Discovery Institute Metabolism, Diabetes and Obesity Program.
